Published in collaboration with NCMS
Digital Manufacturing Report

News & information about the fast-moving world
of digital manufacturing, modeling & simulation

Language Flags

Nanosensors to Lend a Helping Hand to Drug Manufacturers


Chemical engineers at MIT have made a discovery that could help pharmaceutical companies to not only manufacture drugs more efficiently, but it may also allow them to produce drugs in a way that is much safer than before.

Previously, scientists have shown that tiny, nanometer-sized sensors can be used to detect minute quantities of a substance. Now, researchers are trying to see if large arrays of nanosensors can be used to detect many different targets at once. These nanosensors are used to collect and transmit information on the nanoscale and have traditionally been used for science and medical purposes.

The researchers focused on arrays of billions of nanoscale sensors and found that they have certain unique properties that could aid in drug manufacturing. The researchers were able to characterize variations in the binding strength of antibody drugs, which could help to treat cancer. They were also able to monitor the structure of antibody molecules by using the sensors, which allowed the researchers to see if sugars were interfering with the proper function of the molecules. 

“This could help pharmaceutical companies figure out why certain drug formulations work better than others, and may help improve their effectiveness,” says Michael Strano, an MIT professor of chemical engineering and senior author of a recent paper describing the sensors in the journal ACS Nano

Strano and his colleagues were among the researchers that wanted to explore the unique properties that emerge from large arrays of sensors.

Through mathematical modeling and experimentation, Strano and his team discovered that uniform arrays can measure the distribution in binding strength of complex proteins; one example in particular is antibodies.

Since antibodies help the human body to fight off “foreign invaders,” scientists have been using them to treat cancer and other diseases. But in order for the antibodies to be effective, they have to bind to their target—and this doesn’t always happen with the manufacturing process that relies on non-human, engineered cells.

In order to make sure that the antibodies are effective in binding to their targets, drug companies use expensive and time consuming analytical processes to test them. The team from MIT believes that their sensor could assist this process by helping it to move along faster, allowing researchers to better monitor and control production, and by fine-tuning the process, thus producing a more consistent product. 

“You could use the technology to reject batches, but ideally you’d want to use it in your upstream process development to better define culture conditions, so then you wouldn’t produce spurious lots,” said Nigel Reuel, a graduate student at Strano’s lab.

The researchers also found that the sensors are excellent at measuring weak binding interactions.  Antibodies are coated with long sugar chains and these chains are necessary for drugs to be effective. However, they are hard to detect because they interact poorly with other molecules.

“What a nanosensor array can do is greatly expand the number of opportunities to detect rare binding events. You can measure what you would otherwise not be able to quantify with a single, larger sensor with the same sensitivity,” Strano says.

RSS Feeds

Subscribe to All Content


Feature Articles

Titan Puts a New Spin on GE’s Wind Turbine Research

Unlike traditional energy sources, wind is a trouble to tame, which has led GE to turn to advanced simulations at Oak Ridge National Laboratory to put the technology on track to cover 12 percent of the world's energy production.
Read more...

Lighting a Fire Under Combustion Simulation

Combustion simulation might seem like the ultimate in esoteric technologies, but auto companies, aircraft firms and fuel designers need increasingly sophisticated software to serve the needs of 21st century engine designs. HPCwire recently got the opportunity to take a look at Reaction Design, one of the premier makers of combustion simulation software, and talk with its CEO, Bernie Rosenthal.
Read more...

D-Wave Sells First Quantum Computer

On Wednesday, D-Wave Systems made history by announcing the sale of the world's first commercial quantum computer. The buyer was Lockheed Martin Corporation, who will use the machine to help solve some of their "most challenging computation problems." D-Wave co-founder and CTO Geordie Rose talks about the new system and the underlying technology.
Read more...

Short Takes

Local Motors and ORNL Partner for Automotive Manufacturing

Jan 24, 2014 | Local Motors, a vehicle innovator, and the U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL) have announced a new partnership that they hope will bring change to the automotive industry.
Read more...

Advanced Modeling Benefits Wind Farms

May 25, 2011 | Advanced computing resources optimize the site selection of wind farms.
Read more...

Not Your Parents' CFD

Oct 13, 2010 | Outdated beliefs stand in the way of greater CFD adoption.
Read more...

Manufacturers Turn to HPC to Cut Testing Costs

Oct 06, 2010 | Supercomputing saves money by reducing the need for physical testing.
Read more...

HPC Technology Makes Car Safety Job 1

Aug 05, 2010 | Automakers turn to computer simulations to design safer vehicles.
Read more...

Sponsored Whitepapers

Technical Computing for a New Era

07/30/2013 | IBM | This white paper examines various means of adapting technical computing tools to accelerate product and services innovation across a range of commercial industries such as manufacturing, financial services, energy, healthcare, entertainment and retail. No longer is technically advanced computing limited to the confines of big government labs and academic centers. Today it is available to a wide range of organizations seeking a competitive edge.

The UberCloud HPC Experiment: Compendium of Case Studies

06/25/2013 | Intel | The UberCloud HPC Experiment has achieved the volunteer participation of 500 organizations and individuals from 48 countries with the aim of exploring the end-to-end process employed by digital manufacturing engineers to access and use remote computing resources in HPC centers and in the cloud. This Compendium of 25 case studies is an invaluable resource for engineers, managers and executives who believe in the strategic importance of applying advanced technologies to help drive their organization’s productivity to perceptible new levels.

Conferences and Events

Featured Events



Copyright © 2011-2014 Tabor Communications, Inc. All Rights Reserved.
Digital Manufacturing Report is a registered trademark of Tabor Communications, Inc. Use of this site is governed by our Terms of Use and Privacy Policy.
Reproduction in whole or in part in any form or medium without express written permission of Tabor Communications Inc. is prohibited.
Powered by Xtenit.